pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Phase 1
INCA-033989
Essential Thrombocythemia
$INCY
INCYTE CORP
0
catalysts
Phase 1
INCB-100658
Chronic Idiopathic Myelofibrosis (Primary Myelofibrosis)
$INCY
INCYTE CORP
0
catalysts
Phase 2
INKmune
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$INMB
Inmune Bio, Inc.
0
catalysts
Preclinical
← prev
page 23 of 62
next →
131
Pain
89
Neurology
1
INV-441
Glioblastoma Multiforme (GBM)
InvIOs GmbH
0
catalysts
Preclinical
INV-724
Neuroblastoma
Invenra Inc
0
catalysts
Phase 2
INV-9956
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Ionova Life Science Co Ltd
0
catalysts
Phase 2
INX-315
Epithelial Ovarian Cancer
Incyclix Bio LLC
0
catalysts
Phase 1
IO-202
Chronic Myelomonocytic Leukemia (CMML)
Immune Onc Therapeutics Inc
0
catalysts
Preclinical
IO-312
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Immune Onc Therapeutics Inc
0
catalysts
Phase 2
IOV-2001
Chronic Lymphocytic Leukemia (CLL)
$IOVA
IOVANCE BIOTHERAPEUTICS, INC.
0
catalysts
Phase 2
IOV-4001
Metastatic Melanoma
$IOVA
IOVANCE BIOTHERAPEUTICS, INC.
0
catalysts
Phase 2
IPG-7236
Head And Neck Cancer
Immunophage Biotech Co Ltd
0
catalysts
Phase 1
IPH-4502
Breast Cancer
$IPHA
Innate Pharma SA
0
catalysts
Phase 1
ISB-2001
Refractory Multiple Myeloma
$ABBV
AbbVie Inc.
0
catalysts
Phase 1
ISM-3412
Solid Tumor
InSilico Medicine
0
catalysts
Phase 1
ISM-6331
Malignant Mesothelioma
InSilico Medicine
0
catalysts
Preclinical
ISM-9274
Solid Tumor
InSilico Medicine
0
catalysts
Phase 1
ITI-1001
Glioblastoma Multiforme (GBM)
Immunomic Therapeutics Inc
0
catalysts
Phase 1
ITI-3000
Merkel Cell Carcinoma
Immunomic Therapeutics Inc
0
catalysts
Phase 1
IVB-003
Pancreatic Cancer
Invictus Therapeutics Ltd
0
catalysts
Phase 2
IVS-3001
Epithelial Ovarian Cancer
Invectys SA
0
catalysts
Preclinical
IVT-8086
Osteosarcoma
Innova Therapeutics Inc
0
catalysts
Phase 2
ImMucin
Multiple Myeloma (Kahler Disease)
Vaxil Bio Therapeutics Ltd
0
catalysts
Preclinical
Immuno-oncology
Breast Cancer
American Gene Technologies International Inc
0
catalysts
Preclinical
InfiniTIL
Unspecified Cancer
RootPath Genomics Inc
0
catalysts
Phase 1
Innocell Vaccine
Epithelial Ovarian Cancer
PhotonPharma Inc
0
catalysts
Preclinical
IrniCann
(cannabidiol + cannabigerol)
Glioblastoma Multiforme (GBM)
Argent BioPharma Ltd
0
catalysts
Phase 2
JAB-23E73
Metastatic Colorectal Cancer
$AZN
ASTRAZENECA PLC
0
catalysts
Phase 2
JAB-2485
Small-Cell Lung Cancer
Jacobio Pharmaceuticals Group Co Ltd
0
catalysts
Phase 2
JAB-30355
Solid Tumor
Jacobio Pharmaceuticals Group Co Ltd
0
catalysts
